Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson's disease: a systematic review.

Soares NM, Pereira GM, Altmann V, de Almeida RMM, Rieder CRM.

J Neural Transm (Vienna). 2018 Oct 29. doi: 10.1007/s00702-018-1947-4. [Epub ahead of print] Review.

PMID:
30374595
2.

Translation, linguistic and cultural adaptation, reliability and validity of the Radboud Oral Motor Inventory for Parkinson's Disease - ROMP questionnaire.

Presotto M, Olchik MR, Kalf JG, Rieder CRM.

Arq Neuropsiquiatr. 2018 May;76(5):316-323. doi: 10.1590/0004-282X20180033.

3.

Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review.

Mantese CE, Schumacher-Schuh A, Rieder CRM.

Parkinsons Dis. 2018 Apr 1;2018:5308491. doi: 10.1155/2018/5308491. eCollection 2018. Review.

4.

The Impact of Deep Brain Stimulation on the Quality of Life and Swallowing in Individuals with Parkinson's Disease.

Olchik MR, Ghisi M, Ayres A, Schuh AFS, Oppitz PP, Rieder CRM.

Int Arch Otorhinolaryngol. 2018 Apr;22(2):125-129. doi: 10.1055/s-0037-1603466. Epub 2017 Jun 5.

5.

Plantar stimulation in parkinsonians: From biomarkers to mobility - randomized-controlled trial.

Pagnussat AS, Kleiner AFR, Rieder CRM, Frantz A, Ehlers J, Pinto C, Dorneles G, Netto CA, Peres A, Galli M.

Restor Neurol Neurosci. 2018;36(2):195-205. doi: 10.3233/RNN-170744.

PMID:
29526852
6.

Erratum: Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Cornejo-Olivas M, Torres L, Velit-Salazar MR, Inca-Martinez M, Mazzetti P, Cosentino C, Micheli F, Perandones C, Dieguez E, Raggio V, Tumas V, Borges V, Ferraz HB, Rieder CRM, Shumacher-Schuh A, Velez-Pardo C, Jimenez-Del-Rio M, Lopera F, Chang-Castello J, Andreé-Munoz B, Waldherr S, Yearout D, Zabetian CP, Mata IF.

NPJ Parkinsons Dis. 2018 Jan 19;4:3. doi: 10.1038/s41531-017-0025-1. eCollection 2018.

7.

Automated Mechanical Peripheral Stimulation Improves Gait Parameters in Subjects With Parkinson Disease and Freezing of Gait: A Randomized Clinical Trial.

Pinto C, Pagnussat AS, Rozin Kleiner AF, Marchese RR, Salazar AP, Rieder CRM, Galli M.

Am J Phys Med Rehabil. 2018 Jun;97(6):383-389. doi: 10.1097/PHM.0000000000000890.

PMID:
29309313
8.

The future of pharmacogenetics in Parkinson's disease treatment.

Hutz MH, Rieder CR.

Pharmacogenomics. 2018 Feb;19(3):171-174. doi: 10.2217/pgs-2017-0180. Epub 2017 Dec 1. No abstract available.

PMID:
29191064
9.

Brazilian Academy of Neurology (2006 - 2016).

Coelho FM, Castro LH, Fukujima MM, Adoni T, Rieder CRM, Bichuetti DB, Prado GFD, Gagliardi RJ.

Arq Neuropsiquiatr. 2017 Sep;75(9):635-638. doi: 10.1590/0004-282X20170095.

10.

Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.

Lindenau JD, Altmann V, Schumacher-Schuh AF, Rieder CR, Hutz MH.

Neurosci Lett. 2017 Sep 29;658:133-136. doi: 10.1016/j.neulet.2017.08.049. Epub 2017 Aug 24.

PMID:
28844731
11.

Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Cornejo-Olivas M, Torres L, Velit-Salazar MR, Inca-Martinez M, Mazzetti P, Cosentino C, Micheli F, Perandones C, Dieguez E, Raggio V, Tumas V, Borges V, Ferraz HB, Rieder CRM, Shumacher-Schuh A, Velez-Pardo C, Jimenez-Del-Rio M, Lopera F, Chang-Castello J, Andreé-Munoz B, Waldherr S, Yearout D, Zabetian CP, Mata IF.

NPJ Parkinsons Dis. 2017 Jun 2;3:19. doi: 10.1038/s41531-017-0020-6. eCollection 2017. Erratum in: NPJ Parkinsons Dis. 2018 Jan 19;4:3.

12.

Different outcomes of phonemic verbal fluency in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.

Romann AJ, Beber BC, Olchik MR, Rieder CRM.

Arq Neuropsiquiatr. 2017 Apr;75(4):216-220. doi: 10.1590/0004-282X20170024.

13.

Benefit from the Chin-Down Maneuver in the Swallowing Performance and Self-Perception of Parkinson's Disease Patients.

Ayres A, Jotz GP, Rieder CR, Olchik MR.

Parkinsons Dis. 2017;2017:7460343. doi: 10.1155/2017/7460343. Epub 2017 Jan 19.

14.

Deep Brain Stimulation Frequency of the Subthalamic Nucleus Affects Phonemic and Action Fluency in Parkinson's Disease.

Fagundes VC, Rieder CR, da Cruz AN, Beber BC, Portuguez MW.

Parkinsons Dis. 2016;2016:6760243. doi: 10.1155/2016/6760243. Epub 2016 Dec 5.

15.

Association between DNA methyltransferase gene polymorphism and Parkinson's disease.

Pezzi JC, de Bem CM, da Rocha TJ, Schumacher-Schuh AF, Chaves ML, Rieder CR, Hutz MH, Fiegenbaum M, Camozzato AL.

Neurosci Lett. 2017 Feb 3;639:146-150. doi: 10.1016/j.neulet.2016.12.058. Epub 2016 Dec 29.

PMID:
28041964
16.

Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.

Rieck M, Schumacher-Schuh AF, Altmann V, Callegari-Jacques SM, Rieder CRM, Hutz MH.

Pharmacogenomics J. 2018 Jan;18(1):196-200. doi: 10.1038/tpj.2016.79. Epub 2016 Oct 25.

PMID:
27779245
17.

The impact of cognitive performance on quality of life in individuals with Parkinson's disease.

Olchik MR, Ayres A, Ghisi M, Schuh AFS, Rieder CRM.

Dement Neuropsychol. 2016 Oct-Dec;10(4):303-309. doi: 10.1590/s1980-5764-2016dn1004008.

18.

Neuropsychological profile of Parkinson's disease patients selected for deep brain stimulation surgery.

Machado FA, Rieder CR, Hilbig A, Reppold CT.

Dement Neuropsychol. 2016 Oct-Dec;10(4):296-302. doi: 10.1590/s1980-5764-2016dn1004007.

19.

Evaluation of Knee Proprioception and Factors Related to Parkinson's Disease.

Ribeiro Artigas N, Eltz GD, do Pinho AS, Torman VB, Hilbig A, Rieder CR.

Neurosci J. 2016;2016:6746010. doi: 10.1155/2016/6746010. Epub 2016 Sep 8.

20.

Aspects of oral communication in patients with Parkinson's disease submitted to Deep Brain Stimulation.

Cruz AN, Beber BC, Olchik MR, Chaves ML, Rieder CR, Dornelles S.

Codas. 2016 Jul-Aug;28(4):480-5. doi: 10.1590/2317-1782/20162015169. Epub 2016 Aug 18. English, Portuguese.

21.

Postural instability and falls are more frequent in Parkinson's disease patients with worse trunk mobility.

Artigas NR, Franco C, Leão P, Rieder CR.

Arq Neuropsiquiatr. 2016 Jul;74(7):519-23. doi: 10.1590/0004-282X20160074.

22.

Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data.

Chien HF, Rosso ALZ, Santos ASD, Rieder CRM, Maia DP, Silva DJD, Andrade MDC, Coletta MVD, Costa MDDLD, Allam N, Prado RCPD, Borges V, Tumas V, Horta WG.

eNeurologicalSci. 2016 Jul 19;5:11-14. doi: 10.1016/j.ensci.2016.07.001. eCollection 2016 Dec.

23.

The Impact of Dysphagia Therapy on Quality of Life in Patients with Parkinson's Disease as Measured by the Swallowing Quality of Life Questionnaire (SWALQOL).

Ayres A, Jotz GP, Rieder CR, Schuh AF, Olchik MR.

Int Arch Otorhinolaryngol. 2016 Jul;20(3):202-6. doi: 10.1055/s-0036-1582450. Epub 2016 Apr 19.

24.

Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease.

Altmann V, Schumacher-Schuh AF, Rieck M, Callegari-Jacques SM, Rieder CR, Hutz MH.

Pharmacogenomics. 2016 Apr;17(5):481-8. doi: 10.2217/pgs.15.183. Epub 2016 Mar 29.

PMID:
27019953
25.

Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial.

Monteiro EP, Franzoni LT, Cubillos DM, de Oliveira Fagundes A, Carvalho AR, Oliveira HB, Pantoja PD, Schuch FB, Rieder CR, Martinez FG, Peyré-Tartaruga LA.

Scand J Med Sci Sports. 2017 Mar;27(3):351-358. doi: 10.1111/sms.12652. Epub 2016 Feb 2.

PMID:
26833853
26.

Clinical and Epidemiological Factors Associated with Mortality in Parkinson's Disease in a Brazilian Cohort.

Fernandes GC, Socal MP, Schuh AF, Rieder CR.

Parkinsons Dis. 2015;2015:959304. doi: 10.1155/2015/959304. Epub 2015 Dec 27.

27.

Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.

Altmann V, Schumacher-Schuh AF, Rieck M, Callegari-Jacques SM, Rieder CR, Hutz MH.

Neurosci Lett. 2016 Feb 26;615:88-91. doi: 10.1016/j.neulet.2016.01.030. Epub 2016 Jan 21.

28.

Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.

Medeiros MS, Schumacher-Schuh A, Cardoso AM, Bochi GV, Baldissarelli J, Kegler A, Santana D, Chaves CM, Schetinger MR, Moresco RN, Rieder CR, Fighera MR.

PLoS One. 2016 Jan 11;11(1):e0146129. doi: 10.1371/journal.pone.0146129. eCollection 2016.

29.

Assessment of Nonverbal and Verbal Apraxia in Patients with Parkinson's Disease.

Presotto M, Olchik MR, Shumacher Shuh AF, Rieder CR.

Parkinsons Dis. 2015;2015:840327. doi: 10.1155/2015/840327. Epub 2015 Oct 12.

30.

DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease.

Olgiati S, Quadri M, Fang M, Rood JP, Saute JA, Chien HF, Bouwkamp CG, Graafland J, Minneboo M, Breedveld GJ, Zhang J; International Parkinsonism Genetics Network, Verheijen FW, Boon AJ, Kievit AJ, Jardim LB, Mandemakers W, Barbosa ER, Rieder CR, Leenders KL, Wang J, Bonifati V.

Ann Neurol. 2016 Feb;79(2):244-56. doi: 10.1002/ana.24553. Epub 2016 Jan 14.

PMID:
26528954
31.

Author Response.

Fernandes GC, Rieder CR, Vedolin L, Campos L, Koltermann T.

Neurology. 2015 Aug 18;85(7):655. No abstract available.

PMID:
26505051
32.

Overnight S100B in Parkinson's Disease: A glimpse into sleep-related neuroinflammation.

Carvalho DZ, Schönwald SV, Schumacher-Schuh AF, Braga CW, Souza DO, Oses JP, Donis KC, Rieder CR.

Neurosci Lett. 2015 Nov 3;608:57-63. doi: 10.1016/j.neulet.2015.10.010. Epub 2015 Oct 28.

PMID:
26453767
33.

Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.

Saute JA, Rieder CR, Castilhos RM, Monte TL, Schumacher-Schuh AF, Donis KC, D'Ávila R, Souza GN, Russo AD, Furtado GV, Gheno TC, Souza DO, Saraiva-Pereira ML, Portela LV, Camey S, Torman VB, Jardim LB.

J Neurol Sci. 2015 Nov 15;358(1-2):72-6. doi: 10.1016/j.jns.2015.08.019. Epub 2015 Aug 14.

PMID:
26297649
34.

Evaluation of quality of life and psychological aspects of Parkinson's disease patients who participate in a support group.

Artigas NR, Striebel VLW, Hilbig A, Rieder CRM.

Dement Neuropsychol. 2015 Jul-Sep;9(3):295-300. doi: 10.1590/1980-57642015DN93000013.

35.

Genetic of dystonias according the new classification.

Rieder CR.

Arq Neuropsiquiatr. 2015 Apr;73(4):281-2. doi: 10.1590/0004-282X20150058. Epub 2015 Apr 1. No abstract available.

36.

Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients?

Rieck M, Schumacher-Schuh AF, Callegari-Jacques SM, Altmann V, Schneider Medeiros M, Rieder CR, Hutz MH.

Pharmacogenomics. 2015;16(6):573-82. doi: 10.2217/pgs.15.23. Epub 2015 Apr 15.

PMID:
25872644
37.

Teaching NeuroImages: the lentiform fork sign: an MRI pattern of metformin-associated encephalopathy.

Fernandes GC, Koltermann T, Campos L, Vedolin L, Rieder CR.

Neurology. 2015 Jan 20;84(3):e15. doi: 10.1212/WNL.0000000000001154. No abstract available.

PMID:
25601887
38.

NREM sleep alpha and sigma activity in Parkinson's disease: evidence for conflicting electrophysiological activity?

Margis R, Schönwald SV, Carvalho DZ, Gerhardt GJ, Rieder CR.

Clin Neurophysiol. 2015 May;126(5):951-8. doi: 10.1016/j.clinph.2014.07.034. Epub 2014 Aug 27.

PMID:
25227218
39.

Parkinson's disease pharmacogenomics: new findings and perspectives.

Schumacher-Schuh AF, Rieder CR, Hutz MH.

Pharmacogenomics. 2014 Jun;15(9):1253-71. doi: 10.2217/pgs.14.93.

PMID:
25141900
40.

Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson's disease patients.

Schumacher-Schuh AF, Altmann V, Rieck M, Tovo-Rodrigues L, Monte TL, Callegari-Jacques SM, Medeiros MS, Rieder CR, Hutz MH.

Pharmacogenomics J. 2014 Jun;14(3):289-94. doi: 10.1038/tpj.2013.37. Epub 2013 Oct 15.

PMID:
24126708
41.

Huntington disease and Huntington disease-like in a case series from Brazil.

Castilhos RM, Souza AF, Furtado GV, Gheno TC, Silva AL, Vargas FR, Lima MA, Barsottini O, Pedroso JL, Godeiro C Jr, Salarini D, Pereira ET, Lin K, Toralles MB, Saute JA, Rieder CR, Quintas M, Sequeiros J, Alonso I, Saraiva-Pereira ML, Jardim LB.

Clin Genet. 2014 Oct;86(4):373-7. doi: 10.1111/cge.12283. Epub 2013 Oct 17.

PMID:
24102565
42.

Care of patients with Huntington's disease in South America: a survey.

Maciel RO, Cardoso FE, Chaná-Cuevas P, Cosentino C, Fernández W, Rieder CR, Serrano-Dueñas M, Weiser R.

Arq Neuropsiquiatr. 2013 Jun;71(6):368-70. doi: 10.1590/0004-282X20130040.

43.

Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease.

Schumacher-Schuh AF, Francisconi C, Altmann V, Monte TL, Callegari-Jacques SM, Rieder CR, Hutz MH.

Int J Neuropsychopharmacol. 2013 Jul;16(6):1251-1258. Epub 2013 Jan 30.

PMID:
23363854
44.

DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients.

Rieck M, Schumacher-Schuh AF, Altmann V, Francisconi CL, Fagundes PT, Monte TL, Callegari-Jacques SM, Rieder CR, Hutz MH.

Pharmacogenomics. 2012 Nov;13(15):1701-10. doi: 10.2217/pgs.12.149.

PMID:
23171335
45.

Characterization of cognitive and motor performance during dual-tasking in healthy older adults and patients with Parkinson's disease.

Wild LB, de Lima DB, Balardin JB, Rizzi L, Giacobbo BL, Oliveira HB, de Lima Argimon II, Peyré-Tartaruga LA, Rieder CR, Bromberg E.

J Neurol. 2013 Feb;260(2):580-9. doi: 10.1007/s00415-012-6683-3. Epub 2012 Sep 29.

PMID:
23052601
46.

Cognitive assessment instruments in Parkinson's disease patients undergoing deep brain stimulation.

Romann AJ, Dornelles S, Maineri NL, Rieder CRM, Olchik MR.

Dement Neuropsychol. 2012 Jan-Mar;6(1):2-11. doi: 10.1590/S1980-57642012DN06010002. Review.

47.

Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph/spinocerebellar ataxia 3.

Siebert M, Donis KC, Socal M, Rieder CR, Emmel VE, Vairo F, Michelin-Tirelli K, França M Jr, D'Abreu AC, Bettencourt C, Lima M, Lopes Cendes I, Saraiva-Pereira ML, Jardim LB.

Parkinsonism Relat Disord. 2012 Feb;18(2):185-90. doi: 10.1016/j.parkreldis.2011.09.024. Epub 2011 Oct 15.

PMID:
22001711
48.

Reliability and validity of a scale for measurement of trunk mobility in Parkinson's disease: Trunk Mobility Scale.

Franco CR, Leão P, Townsend R, Rieder CR.

Arq Neuropsiquiatr. 2011 Aug;69(4):636-41.

49.

Topiramate is effective for status epilepticus and seizure control in neuraminidase deficiency.

Bragatti JA, Torres CM, Netto CB, Vedolin L, Garzon E, Rieder CR, Schwartz IV, Bianchin MM.

Arq Neuropsiquiatr. 2011 Jun;69(3):565-6. No abstract available.

50.

Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures.

Bianchin MM, Bragatti JA, Torres CM, Nuernberg GL, Rieder CR.

Neurology. 2011 May 17;76(20):1772; author reply 1772-3. doi: 10.1212/WNL.0b013e318219a086. No abstract available.

PMID:
21576697

Supplemental Content

Loading ...
Support Center